US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Distillate Small/Mid Cash Flow ETF

39.49

+0.23490.60%

Volume:5K

Turnover:189.46K

Market Cap:124.40M

PE:- -

High:39.58

Open:39.38

Low:39.37

Close:39.26

52wk High:40.97

52wk Low:32.02

Shares:3.15M

Float Shares:3.15M

Volume Ratio:0.90

T/O Rate:0.15%

Dividend:0.45

Dividend Rate:1.14%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

EyePoint receives positive DSMC recommendation for Duravyu Phase 3 trials

Radiopharm Theranostics Reports Business Update

Radiopharm Theranostics Presents Initial Findings from Phase 1 First-in-Human HEAT Clinical Trial for 177Lu-RAD202 in HER2+ Solid Tumors at American Association for Cancer Research 2026

Radiopharm Theranostics Advances to Cohort 3 in 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/DSMC"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DSMC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DSMC\",,,,,undefined,":{"symbol":"DSMC","market":"US","secType":"STK","nameCN":"Distillate Small/Mid Cash Flow ETF","latestPrice":39.4915,"timestamp":1782244800000,"preClose":39.2566,"halted":0,"volume":4798,"delay":0,"changeRate":0.005983707198280117,"floatShares":3150000,"shares":3150000,"eps":0,"marketStatus":"Pre-Mkt","change":0.2349,"latestTime":"06-24 07:52:54 EDT","open":39.38,"high":39.58,"low":39.3651,"amount":189457,"amplitude":0.005474,"askPrice":62.79,"askSize":100,"bidPrice":15.88,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1782307800000},"marketStatusCode":1,"adr":0,"exchange":"NYSE","adjPreClose":39.4915,"sharesOutstanding":3225000,"nav":39.22,"aum":123543000,"dividendRate":0.011433,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":39.49,"preClose":39.4915,"latestTime":"16:10 EDT","volume":6,"amount":236.949,"timestamp":1782245404954,"change":-0.0015,"changeRate":-0.000038,"amplitude":0},"volumeRatio":0.8994788279443678,"impliedVol":0.1509,"impliedVolPercentile":0.816},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DSMC\",,,,,undefined,":{"symbol":"DSMC","floatShares":3150000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.8994788279443678,"shares":3150000,"dividePrice":0.4515,"high":39.58,"amplitude":0.005474,"preClose":39.2566,"low":39.3651,"week52Low":32.02,"pbRate":"--","week52High":40.97,"institutionHeld":0,"latestPrice":39.4915,"eps":0,"divideRate":0.011433,"volume":4798,"delay":0,"ttmEps":0,"open":39.38,"prevYearClose":35.47,"prevWeekClose":39.58,"prevMonthClose":39.9582,"prevQuarterClose":37.4231,"fiveDayClose":40.316,"twentyDayClose":39.4794,"sixtyDayClose":37.53},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DSMC\",params:#limit:5,,,undefined,":[{"date":"2026-03-26","symbol":"DSMC","amount":0.10517254,"announcedDate":"2026-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-26","defaultRemindTime":1774531800000,"name":"Distillate Small/Mid Cash Flow ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-26","currency":"USD","dateTimestamp":1774497600000,"payDate":"2026-03-27"},{"date":"2025-12-29","symbol":"DSMC","amount":0.15085733,"announcedDate":"2025-12-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-29","defaultRemindTime":1767018600000,"name":"Distillate Small/Mid Cash Flow ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-30","payableDate":"2025-12-29","currency":"USD","dateTimestamp":1766984400000,"payDate":"2025-12-30"},{"date":"2025-09-24","symbol":"DSMC","amount":0.08622672,"announcedDate":"2025-09-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-24","defaultRemindTime":1758720600000,"name":"Distillate Small/Mid Cash Flow ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-25","payableDate":"2025-09-24","currency":"USD","dateTimestamp":1758686400000,"payDate":"2025-09-25"},{"date":"2025-06-25","symbol":"DSMC","amount":0.1076,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-25","defaultRemindTime":1750858200000,"name":"Distillate Small/Mid Cash Flow ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-26","payableDate":"2025-06-25","currency":"USD","dateTimestamp":1750824000000,"payDate":"2025-06-26"},{"date":"2025-03-26","symbol":"DSMC","amount":0.075599,"announcedDate":"2025-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-26","defaultRemindTime":1742995800000,"name":"Distillate Small/Mid Cash Flow ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-27","payableDate":"2025-03-26","currency":"USD","dateTimestamp":1742961600000,"payDate":"2025-03-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DSMC\",market:\"US\",,,undefined,":[{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.073726,"currency":"USD"},{"executeDate":"2023-03-22","recordDate":"2023-03-23","paymentDate":"2023-03-24","value":0.069972,"currency":"USD"},{"executeDate":"2023-06-21","recordDate":"2023-06-22","paymentDate":"2023-06-23","value":0.089299,"currency":"USD"},{"executeDate":"2023-09-20","recordDate":"2023-09-21","paymentDate":"2023-09-22","value":0.086071,"currency":"USD"},{"executeDate":"2023-12-27","recordDate":"2023-12-28","paymentDate":"2023-12-29","value":0.107254,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DSMC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DSMC\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2635374633","title":"EyePoint receives positive DSMC recommendation for Duravyu Phase 3 trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2635374633","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635374633?lang=en_us&edition=fundamental","pubTime":"2026-05-14 22:31","pubTimestamp":1778769085,"startTime":"0","endTime":"0","summary":"EyePoint (EYPT) announced the independent data safety monitoring committee completed its third scheduled review of the company’s pivotal Phase 3 pr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eyepoint-receives-positive-dsmc-recommendation-for-duravyu-phase-3-trials-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eyepoint-receives-positive-dsmc-recommendation-for-duravyu-phase-3-trials-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LU0889565916.HKD","BK4588","LU0320765992.SGD","DSMC","BK4585","LU0109394709.USD","EYPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629783311","title":"Radiopharm Theranostics Reports Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2629783311","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629783311?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:00","pubTimestamp":1776942000,"startTime":"0","endTime":"0","summary":"Completed enrolment in Phase 2b clinical trial of imaging agent RAD 101 in patients with recurrent brain metastases following earlier announcement of interim data demonstrating concordance with MRI (t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/23/3279721/0/en/Radiopharm-Theranostics-Reports-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SOC","DSMC","RAD","BK4128","BK4139","BK4213","IE0009354923.USD","BK4183","ODD","RADX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628984742","title":"Radiopharm Theranostics Presents Initial Findings from Phase 1 First-in-Human HEAT Clinical Trial for 177Lu-RAD202 in HER2+ Solid Tumors at American Association for Cancer Research 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2628984742","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628984742?lang=en_us&edition=fundamental","pubTime":"2026-04-20 19:00","pubTimestamp":1776682800,"startTime":"0","endTime":"0","summary":"177Lu-RAD202 demonstrated encouraging tumor uptake and a favorable safety profile in the lowest dose cohort Data Safety and Monitoring Committee Recently Approved Advancing 177Lu-RAD202 to Next Highes","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/20/3276868/0/en/Radiopharm-Theranostics-Presents-Initial-Findings-from-Phase-1-First-in-Human-HEAT-Clinical-Trial-for-177Lu-RAD202-in-HER2-Solid-Tumors-at-American-Association-for-Cancer-Research-.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEAT","RADX","BK4139","RAD","BK4107","BK4117","DSMC","BK4128","AFG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625949153","title":"Radiopharm Theranostics Advances to Cohort 3 in 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2625949153","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625949153?lang=en_us&edition=fundamental","pubTime":"2026-04-08 19:00","pubTimestamp":1775646000,"startTime":"0","endTime":"0","summary":"Receives Positive Recommendation from Data Safety and Monitoring Committee (DSMC) to progress Phase 1 to the next dose level of 130mCi in patients with HER2+ advanced solid tumorsSYDNEY, April  08, 20","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/08/3269961/0/en/Radiopharm-Theranostics-Advances-to-Cohort-3-in-177Lu-RAD202-Phase-1-Dose-Escalating-Clinical-Trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RADX","BK4139","BK4128","RAD","DSMC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/DSMC\",params:#limit:6,delay:false,,,undefined,":[]}}